Explainer
Copper peptides and vitamin C: what the formulation research says
Prepared by: Research Desk. Sources are linked for verification.
Few skincare questions come up as often as whether copper peptides and vitamin C belong in the same bottle. Both are widely used cosmetic ingredients, and both are often marketed with confident claims. When they are combined, though, the conversation shifts from marketing to chemistry. Ascorbic acid is a reducing agent, and copper is a redox-active metal. That pairing has a long history in the free-radical literature.
This explainer sets out what each ingredient is and why their chemistry raises formulation questions. It then covers what stability research reports and, just as important, what nobody in our source list has measured directly. For a broader introduction to the copper peptide itself, see our researcher's guide to GHK-Cu.
Two very different molecules
Vitamin C in cosmetic science
The form of vitamin C most studied in topical products is L-ascorbic acid. A 2017 review of topical vitamin C describes its roles as an antioxidant and as a cofactor in collagen synthesis. The same review notes its main formulation weakness: L-ascorbic acid is unstable [1]. It oxidises readily on exposure to air, light and heat. The review also describes acidic conditions as a factor in getting it into the skin, which shapes how products are formulated [1].
Because of that instability, chemists have developed many derivatives. Examples include magnesium ascorbyl phosphate, sodium ascorbyl phosphate, ascorbyl glucoside and tetrahexyldecyl ascorbate. A 2022 review of these derivatives compared the published data and reported that the evidence base for many of them is thinner than for L-ascorbic acid itself [2]. A 2025 review of topical vitamin C and its derivatives in dermatology and cosmetics covers the same trade-off. More stable forms may behave differently from the parent molecule, and comparisons between them are limited [3].
One of the most cited formulation papers in this area tested stabilisation directly. Lin and colleagues added ferulic acid to a solution of vitamins C and E. They reported that the solution was more chemically stable and that its photoprotection doubled [4]. Those protection measurements were made on pig skin, an animal model, not in a human trial. The paper matters for this topic because it shows that the chemical environment around ascorbic acid can measurably change how long it lasts.
GHK-Cu as a metal complex
GHK is the tripeptide glycyl-L-histidyl-L-lysine. Its defining chemical property is a strong affinity for copper(II) ions. The resulting complex, GHK-Cu, is what labels usually list as copper tripeptide-1 [5]. Pickart's reviews summarise cell-culture and animal work on tissue remodelling. They also cover gene-expression analyses, which are computational comparisons of cell data, not measurements in people [6][7].
A 2025 review of topically applied GHK looked at both its advantages and its problems as a cosmetic ingredient. Among the problems it discussed were stability and getting the peptide through the skin barrier [8]. That framing is useful here. GHK-Cu is a coordination complex, so its behaviour in a formula depends on the copper staying bound to the peptide.
The core issue: ascorbate and copper redox chemistry
The paper most directly relevant to this pairing is a 1996 review by Buettner and Jurkiewicz. Its title is Catalytic metals, ascorbate and free radicals: combinations to avoid [9]. It describes a well-established reaction sequence:
Ascorbate donates electrons to transition metals. It reduces copper(II) to copper(I) and iron(III) to iron(II).
The reduced metal can react with oxygen and with hydrogen peroxide. These reactions generate reactive oxygen species, including the hydroxyl radical.
The ascorbate is used up along the way, so its antioxidant capacity is consumed rather than conserved.
The paper's point is that a reducing agent plus a catalytic metal can turn an antioxidant into a source of oxidants [9]. Its scope needs stating clearly, however. It concerns metals in experimental and biological solutions. It does not test cosmetic formulations or GHK-Cu specifically. When copper is bound to a peptide, its redox behaviour changes compared with free copper ions. How far the GHK complex protects copper from reduction by ascorbate in a cosmetic base is not measured in any source we reviewed.
From this chemistry, formulators usually raise three separate concerns:
Loss of vitamin C. Copper-catalysed oxidation could shorten the shelf life of ascorbic acid in a product.
Change to the copper complex. Reducing copper(II) could alter or weaken its binding to GHK.
Pro-oxidant chemistry in the product. Metal-catalysed reactions could produce oxidants rather than neutralise them.
Each of these is a reasonable hypothesis grounded in general redox chemistry. None of them is a measured finding about a specific product.
pH: two ingredients pulling in different directions
The second tension is acidity. As noted above, L-ascorbic acid products are typically formulated at acidic pH [1]. In general coordination chemistry, metal binding by peptides depends on groups such as the histidine imidazole ring being deprotonated. Strongly acidic conditions tend to favour release of the metal.
That is a general principle, not a result from our source list. We did not find a study in the sources available to us that measured GHK-Cu dissociation at the pH used in L-ascorbic acid serums. The 2025 GHK review lists stability among the ingredient's open problems [8]. That is consistent with this question still being largely unmeasured in the public literature.
Delivery vehicles add another variable
The base a product is built on also matters. A review of microemulsions as transdermal delivery vehicles describes how the choice of vehicle changes how compounds partition into and across the skin [10]. For a two-ingredient product, the vehicle is not neutral. It can separate ingredients into different phases or bring them into closer contact. Neither outcome has been characterised for vitamin C and GHK-Cu together in the sources reviewed here.
What the literature does not show
It is worth being explicit about the gaps:
No head-to-head stability study in our source list measures a combined vitamin C and GHK-Cu product over time.
No human study in our source list compares a combined product with separate products.
Derivatives are untested in this context. More stable vitamin C forms are often suggested as "copper-friendly", but the derivative reviews [2][3] do not test interactions with copper complexes.
Industry rules of thumb about separating the two ingredients are extrapolations from general chemistry [9], not trial results.
How regulators view these products
In the United States, the FDA classifies a product by its intended use. Intended use is shown largely by the claims made for it. A serum marketed to change the structure or function of the body can be regulated as a drug, even if its ingredients are common cosmetic ones [11]. Under the Modernization of Cosmetics Regulation Act of 2022, cosmetic companies have duties such as facility registration, product listing and safety substantiation. None of these amounts to an FDA approval [12]. Our explainer on the legal status of GHK-Cu covers the topical versus injectable distinction in more detail.
How to compare vitamin C and copper serums on a label
Without published data on combined formulas, a label is the best evidence a reader has. These criteria are neutral and checkable:
The vitamin C form. Check whether the ingredient list names L-ascorbic acid or a specific derivative. They differ in stability and in the depth of published evidence [2].
The copper ingredient. Look for "copper tripeptide-1" in the INCI list and note where it appears in the order.
One bottle or two. Check whether the brand sells the ingredients in a single formula or as separate products, and whether it explains why.
Stabilisers. Look for named antioxidants such as ferulic acid or tocopherol, the combination studied by Lin and colleagues [4].
Packaging. Opaque, airless or pump packaging limits the light and air exposure that degrade ascorbic acid [1].
Dating. Look for a batch code, an expiry date and a period-after-opening symbol.
Claim language. Drug-like claims on a cosmetic are a regulatory warning sign [11].
Price transparency. Check whether the price per unit volume is stated, and whether the return policy is clear before purchase.
Tools for comparing products
Retailers differ in how much product detail they show. Useful listings give the full ingredient list, packaging photos, size and unit pricing, and a clear return policy. The links we may add here are chosen on those criteria, and our about page explains how affiliate links work on this site.
Retailer listings are not independent evidence. Ingredient lists and dating information remain the most reliable points of comparison, and marketing copy on a product page should be read as a claim, not a finding.
Frequently asked questions
Does vitamin C break down copper peptides?
General redox chemistry shows that ascorbate reduces copper(II) to copper(I), and that this can drive oxidant-forming reactions [9]. Whether this meaningfully disrupts the GHK-Cu complex in a finished cosmetic has not been measured in the sources we reviewed. It is a plausible formulation concern, not a demonstrated result.
Why do some serums use vitamin C derivatives instead of pure ascorbic acid?
Derivatives were developed mainly because L-ascorbic acid oxidises quickly and needs acidic conditions [1]. Reviews report that many derivatives are more stable but have a smaller evidence base than the parent molecule [2][3]. How they interact with copper complexes has not been studied in the sources listed here.
Is a serum that contains both ingredients a drug?
Under U.S. rules, classification depends mainly on a product's intended use as shown by its claims, not on the ingredients alone [11]. A serum sold with cosmetic claims is regulated as a cosmetic and is subject to MoCRA duties, which are not an approval [12].
Last updated: 19 October 2026.
Related on this site
Not medical advice. This page reports published research and regulatory records for information only.
Research-only notice: Content on this site is provided for research and educational purposes only and is not intended for human use. It is not medical advice.
Translation notice: Some content on this site may have been machine-translated using Google Translate and may contain errors.
Sources
Prepared by
Research Desk